Skip to main content
. 2017 Feb 6;10:44. doi: 10.1186/s13045-017-0414-2

Fig. 2.

Fig. 2

Distribution of the patients according to their reduction in RUNX1-RUNX1T1 transcript levels at 1–3 months and relapse time after allo-HSCT